Status:
COMPLETED
Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice
Lead Sponsor:
Sun Pharmaceutical Industries, Inc.
Conditions:
Lice Infestations
Eligibility:
All Genders
2+ years
Phase:
PHASE3
Brief Summary
Current treatments for head lice include over-the-counter products such as permethrin and prescription products such as OVIDE (malathion 0.5%) lotion. In a previous phase II study, a novel, easy-to-us...
Eligibility Criteria
Inclusion
- Confirmed active head lice infestation
- Patient, parent or guardian must be able to apply the treatment
- Entire household must be screened
- All infested persons must agree to participate
Exclusion
- Allergy to pediculicides, hair care products or chrysanthemums
- Scalp conditions other than head lice
- Previous head lice treatment within the past 4 weeks
- Female patients who are pregnant or nursing
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT00244439
Start Date
December 1 2005
End Date
December 1 2006
Last Update
December 23 2013
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Investigator Site
Scottsdale, Arizona, United States
2
Investigator Site
Miami, Florida, United States
3
Investigator Site
St. Petersburg, Florida, United States
4
Investigator Site
West Palm Beach, Florida, United States